Biotech chairman strikes after just 35 days in office
Without a new board of directors and a new strategy things could have gone very wrong. Billions would have been lost in shareholders’ value and focus on the most promising project would have been too weak. That’s why we react as we do; with a total restructuring of the company, replacement of the management and massive lay-offs of employees.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.